Loading company…
Riskpilot
← Back to search
Sign in
Get full access
EPIDEMIEN AS
AS
Active
Org 929134842
Åbødalsveien 79, 4200 Sauda
Rental and operating of own or leased real estate · NACE 6820
Est. 2022
0 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
NOK 221K
+19% vs 2023
EBITDA margin
32.7%
+68% vs 2023
Equity ratio
96.7%
Financial strength
Net profit 2024
NOK 26K
+692% vs 2023
EBITDA — year on year
NOK millions
0M
-0M
-1M
-1M
-1M
0M
2022
0M
0%
2023
0M
0%
2024
Key figures
Annual report 2024
Revenue
NOK 221K
+19%
EBITDA
NOK 72K
+68%
Net profit
NOK 26K
+692%
Total assets
NOK 2,1M
+3%
Equity
NOK 2,1M
+1%
Employees
0
—
Company information
Legal name
EPIDEMIEN AS
Org number
929134842
Legal form
Aksjeselskap
NACE code
6820 · Rental and operating of own or leased real estate
Founded
3. mai 2022
Share capital
NOK 2 000 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap.
Company purpose
Utvikling, drift og utleie av eiendom, samt alt som derved er forbundet.
Contact
Address
Åbødalsveien 79, 4200 Sauda
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Rental and operating of own or leased real estate
Companies in Sauda
All Norway companies
Revenue
NOK millions
0M
0M
1M
1M
1M
0M
2022
0M
2023
0M
2024
EBITDA
NOK millions
0M
0M
1M
1M
1M
0M
2022
0M
2023
0M
2024
Income statement
NOK thousands
Item
2022
2023
2024
Revenue
102
186
221
Staff expenses
−0
−0
−0
EBITDA
56
43
72
Depreciation & amort.
−23
−40
−40
EBIT
33
3
32
Net financials
0
1
1
Profit before tax
33
4
33
Tax
7
1
7
Net profit
25
3
26
Balance sheet
NOK thousands
Item
2022
2023
2024
Total assets
2 078
2 058
2 124
Equity
2 025
2 029
2 054
Long-term debt
29
28
3
Short-term debt
24
1
66
Total debt
52
30
69
Financial ratios
5-year trend
EBITDA margin
32.7%
This company
15.8%
Market median
+107% vs market
2022
2024
Equity ratio
96.7%
This company
38.2%
Market median
+153% vs market
2022
2024
Return on equity
1.2%
This company
18.4%
Market median
-93% vs market
2022
2024
Net profit margin
11.6%
This company
8.1%
Market median
+43% vs market
2022
2024
Asset turnover
0.10×
This company
1.12×
Market median
-91% vs market
2022
2024
Debt / equity
0.03×
This company
0.62×
Market median
+95% vs market
2022
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-03-01 – 2022-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (4)
KL
Kristian Landro
Chairman
2025
HS
Helge Svandal
Board of Directors
2022
KK
Karl-Dag Kjosavik
Chairman
2022
BK
Bjørn Kåre Bergesen
Board of Directors
2022
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Ryfylke Verdi As
Company
75%
75%
2024
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
Kdi As
Neema Invest As
Ryfylke Verdi As
EPIDEMIEN AS
(this company)
Board network connections
Board members of EPIDEMIEN AS also hold positions in
0
other companies.
Person
Role here
Other companies
Kristian Landro
Chairman
0 companies
Helge Svandal
Board of Directors
0 companies
Karl-Dag Kjosavik
Chairman
0 companies
Bjørn Kåre Bergesen
Board of Directors
0 companies